Current
Neuro-Oncology

Volume 18 Number 4
30 April 2016

Home > Publications > Current Neuro-Oncology > Volume 18, Year 2016 > Number 4, 30 April

De Bacco F, D'Ambrosio A, Casanova E, Orzan F, Neggia R, Albano R, Verginelli F, Cominelli M, Poliani PL, Luraghi P, Reato G, Pellegatta S, Finocchiaro G, Perera T, Garibaldi E, Gabriele P, Comoglio PM, Boccaccio C.
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.
EMBO Mol Med. 2016 April 4, 2016;8(5):550-68→. doi: 10.15252/emmm.201505890→. PMID: 27138567→. Laboratory investigation. ˍ

Seliger C, Meier CR, Becker C, Jick SS, Bogdahn U, Hau P, Leitzmann MF.
Statin use and risk of glioma: population-based case-control analysis.
Eur J Epidemiol. 2016 Apr 4, 2016;31(9):947-52→. doi: 10.1007/s10654-016-0145-7→. PMID: 27041698→. Observational study. ˍ

Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ Jr.
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
N Engl J Med. 2016 Apr 7, 2016;374(14):1344-55→. doi: 10.1056/NEJMoa1500925→. PMID: 27050206→. Interventional study. ˍ

Rivoirard R, Chargari C, Guy JB, Nuti C, Peoc'h M, Forest F, Falk AT, Garin C, Adjabi A, Hoarau D, Fotso MJ, Langrand Escure J, Moriceau G, Fournel P, Boutet C, Magné N.
Clinical Impact of Bevacizumab in Patients with Relapsed Glioblastoma: Focus on a Real-Life Monocentric SurVey (SV1 Study).
Chemotherapy. 2016 Apr 9, 2016;61(5):269-74→. doi: 10.1159/000443719→. PMID: 27057742→. Observational study; ˍ

Farah P, Blanda R, Kromer C, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.
Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995-2012.
J Neurooncol. 2016 Apr 19, 2016;128(3):419-29→. doi: 10.1007/s11060-016-2127-8→. PMID: 27095247→. Observational study; ˍ

Du Four S, Maenhout SK, Benteyn D, De Keersmaecker B, Duerinck J, Thielemans K, Neyns B, Aerts JL.
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.
Cancer Immunol Immunother. 2016 Apr 20, 2016;65(6):727-40→. doi: 10.1007/s00262-016-1836-3→. PMID: 27098427→. Interventional study; ˍ

Schäfer N, Gielen GH, Kebir S, Wieland A, Till A, Mack F, Schaub C, Tzaridis T, Reinartz R, Niessen M, Fimmers R, Simon M, Coch C, Fuhrmann C, Herrlinger U, Scheffler B, Glas M.
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.
J Cancer Res Clin Oncol. 2016 Apr 21, 2016;142(7):1581-9→. doi: 10.1007/s00432-016-2161-0→. PMID: 27100354→. Interventional study; ˍ

Eryılmaz MK, Mutlu H, Yalçin Müsri F, Salim DK, Tazegül G, Coşkun HŞ.
Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme.
J Oncol Pharm Pract. 2016 Apr 22, 2017;23(5):392-395→. doi: 10.1177/1078155216643858→. PMID: 27105898→. Case report; ˍ

Wetmore C, Daryani VM, Billups CA, Boyett JM, Leary S, Tanos R, Goldsmith KC, Stewart CF, Blaney SM, Gajjar A.
Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021.
Cancer Med. 2016 Apr 25, 2016;5(7):1416-24→. doi: 10.1002/cam4.713→. PMID: 27109549→. Interventional study. ˍ

English M, Grundy RG, Peet A, Lowis S, Walker D.
Proton beam therapy for medulloblastoma.
Lancet Oncol. 2016 Apr 27, 2016;17(5):e174→. doi: 10.1016/S1470-2045(16)00102-9→. PMID: 27301037→. Comment. ˍ
Refers to: Yock TI, et al., Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Jan 29, 2016;17(3):287-298→. doi: 10.1016/S1470-2045(15)00167-9→. PMID: 26830377→. Interventional study. ˍ
Erratum in: Lancet Oncol. 2020 Mar;21(3):e132→. doi: 10.1016/S1470-2045(20)30104-2→. PMID: 32135116→. Correction. ˍ
Author’s reply: Yock TI, et al., Proton beam therapy for medulloblastoma - Author's reply.
Lancet Oncol. 2016 Apr 27. 2016;17(5):e174-5→. doi: 10.1016/S1470-2045(16)30061-4→. PMID: 27301036→. Comment. ˍ

Jones B.
Proton beam therapy for medulloblastoma.
Lancet Oncol. 2016 Apr 27. 2016;17(5):e173. doi: 10.1016/S1470-2045(16)00084-X. Comment. Source Similar articles
Refers to: Yock TI, et al., Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Jan 29, 2016;17(3):287-298→. doi: 10.1016/S1470-2045(15)00167-9→. PMID: 26830377→. Interventional study. ˍ
Erratum in: Lancet Oncol. 2020 Mar;21(3):e132→. doi: 10.1016/S1470-2045(20)30104-2→. PMID: 32135116→. Correction. ˍ
Author’s reply: Yock TI, et al., Proton beam therapy for medulloblastoma - Author's reply.
Lancet Oncol. 2016 Apr 27. 2016;17(5):e174-5→. doi: 10.1016/S1470-2045(16)30061-4→. PMID: 27301036→. Comment. ˍ

Ramaswamy V, Bouffet E.
Proton beam therapy for medulloblastoma.
Lancet Oncol. 2016 Apr 27, 2016;17(5):e173-4. doi: 10.1016/S1470-2045(16)00156-X. Comment. Source Similar articles
Refers to: Yock TI, et al., Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Jan 29, 2016;17(3):287-298→. doi: 10.1016/S1470-2045(15)00167-9→. PMID: 26830377→. Interventional study. ˍ
Erratum in: Lancet Oncol. 2020 Mar;21(3):e132→. doi: 10.1016/S1470-2045(20)30104-2→. PMID: 32135116→. Correction. ˍ
Author’s reply: Yock TI, et al., Proton beam therapy for medulloblastoma - Author's reply.
Lancet Oncol. 2016 Apr 27. 2016;17(5):e174-5→. doi: 10.1016/S1470-2045(16)30061-4→. PMID: 27301036→. Comment. ˍ

Yock TI, Tarbell NJ, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ.
Proton beam therapy for medulloblastoma - Author's reply.
Lancet Oncol. 2016 Apr 27. 2016;17(5):e174-5→. doi: 10.1016/S1470-2045(16)30061-4→. PMID: 27301036→. Comment. ˍ
Refers to commentators of the article: Yock TI, et al., Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Lancet Oncol. 2016 Jan 29, 2016;17(3):287-298→. doi: 10.1016/S1470-2045(15)00167-9→. PMID: 26830377→. Interventional study. ˍ
Erratum in: Lancet Oncol. 2020 Mar;21(3):e132→. doi: 10.1016/S1470-2045(20)30104-2→. PMID: 32135116→. Correction. ˍ